Acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Or... — RxCUI 1116568
RxNorm drug concept · Semantic clinical drug
RxCUI 1116568
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1116568
Official nameAcetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 650 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution; acetaminophen 650 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG in 20 mL Oral Solution; acetaminophen 325 MG / guaifenesin 200 MG / phenylephrine HCl 5 MG per 10 ML Oral Solution; acetaminophen 650 MG / guaifenesin 400 MG / phenylephrine HCl 10 MG per 20 ML Oral Solution; APAP 32.5 MG/ML / Guaifenesin 20 MG/ML / Phenylephrine Hydrochloride 0.5 MG/ML Oral Solution
FDA products mapped9
Package NDCs mapped9
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
- I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
- You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
- Can I use the nasal spray if I have high blood pressure or heart disease?
🕸️ Concept Web — How Acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution
RxCUI 1116568 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 5
The active substance itself — no strength, form, or brand attached yet.
-
Acetaminophen
161IN -
Guaifenesin
5032IN -
Phenylephrine
8163IN -
Acetaminophen / guaifenesin / phenylephrine
631158MIN -
Phenylephrine hydrochloride
8164PIN
-
Acetaminophen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Acetaminophen / guaifenesin / phenylephrine Oral Solution
827756SCDF -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Solution
2648955SCDFP -
Acetaminophen / guaifenesin / phenylephrine Oral Liquid Product
1151222SCDG -
Acetaminophen / guaifenesin / phenylephrine Oral Product
1151223SCDG -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Liquid Product
2659601SCDGP -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Product
2663602SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Acetaminophen / guaifenesin / phenylephrine Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Acetaminophen 32.5 MG/ML
336021SCDC -
Guaifenesin 20 MG/ML
316011SCDC -
Phenylephrine hydrochloride 0.5 MG/ML
707273SCDC
-
Acetaminophen 32.5 MG/ML
-
Packs 1
Fixed collections of drugs packaged and sold together, like dose packs.
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
{1 (acetaminophen 32.5 MG/ML / dextromethorphan hydrobromide 1 MG/ML / phenylephrine hydrochloride 0.5 MG/ML / triprolidine hydrochloride 0.125 MG/ML Oral Solution) / 1 (acetaminophen 32.5 MG/ML / guaifenesin 20 MG/ML / phenylephrine hydrochloride 0.5 MG/ML Oral Solution) } Pack
GPCK · 2397132 -
Acetaminophen 32.5 MG/ML
SCDC · 336021 -
Guaifenesin 20 MG/ML
SCDC · 316011 -
Phenylephrine hydrochloride 0.5 MG/ML
SCDC · 707273 -
Acetaminophen / guaifenesin / phenylephrine Oral Solution
SCDF · 827756 -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Solution
SCDFP · 2648955 -
Acetaminophen / guaifenesin / phenylephrine Oral Liquid Product
SCDG · 1151222 -
Acetaminophen / guaifenesin / phenylephrine Oral Product
SCDG · 1151223 -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Liquid Product
SCDGP · 2659601 -
Acetaminophen / guaifenesin / phenylephrine hydrochloride Oral Product
SCDGP · 2663602
📦 FDA Products & Package NDCs
9 products · 9 package NDCs
9 package NDCs map to RxCUI 1116568 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 49035-0478-06 | 177 mL in 1 BOTTLE, PLASTIC (49035-478-06) | Severe Congestion and Sinus Relief Maximum Strength | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 2018-04-30 |
| 53041-0616-58 | 177 mL in 1 BOTTLE (53041-616-58) | Tussnex FM Cold and Sinus | Guardian Drug Company | 2012-12-01 |
| 53942-0515-25 | 177 mL in 1 BOTTLE (53942-515-25) | Cold and Sinus Maxium Strength | DeMoulas Market Basket | 2013-09-19 |
| 55910-0757-09 | 266 mL in 1 BOTTLE, PLASTIC (55910-757-09) | Mucus Relief Congestion and Headache Maximum Strength | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 2019-06-01 |
| 63824-0115-66 | 1 KIT in 1 CARTON (63824-115-66) * 180 mL in 1 BOTTLE (638... | Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain and Mucinex Nightshift Sinus | Reckitt Benckiser LLC | 2022-05-30 |
| 63824-0266-66 | 180 mL in 1 BOTTLE (63824-266-66) | Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain | Reckitt Benckiser LLC | 2018-03-01 |
| 65131-0054-18 | 1 BOTTLE, PLASTIC in 1 BOX (65131-054-18) / 120 mL in 1 BOT... | BRONCOCHEM KIDS COLD AND FLU | LABORATORIO MAGNACHEM INTERNATIONAL SRL | 2017-05-01 |
| 69842-0717-06 | 180 mL in 1 BOTTLE (69842-717-06) | CVS Severe Congestion and Pain Relief | CVS | 2020-03-30 |
| 76281-0515-25 | 177 mL in 1 BOTTLE (76281-515-25) | Maximum strength Max Cold and Sinus | AptaPharma Inc. | 2024-01-30 |
Observed labelers:
Reckitt Benckiser LLC (2) ·
AptaPharma Inc. (1) ·
CVS (1) ·
DeMoulas Market Basket (1) ·
Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) (1) ·
EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.